During this session, the panelists discussed the role of market access in making investment decisions within the healthcare sector. The conversation covered various aspects, including the importance ...

At Sanofi, every decision we make is driven by our purpose to improve the lives of people diagnosed with disease – whatever their circumstances, ensuring that we remain a driving force for advancing ...

Private markets are growing rapidly. Just ten years ago, they represented around $4 trillion in assets. Today that number has grown to about $15 trillion, and industry estimates maintain that pace of ...

Fingerpaint Group has secured yet another acquisition to boost its portfolio, this time expanding its market access capabilities. On Wednesday, the MM+M 2024 Agency 100 honoree announced that it is ...

Klick Health is taking a fellow life-sci-centric agency under its wing. The marketing giant announced Tuesday that it has acquired Peregrine Market Access, a Saratoga Springs, New York-based firm ...

Entrée Health distinguished itself in 2023 by evolving its branding system, better describing the essence of its work, diverse teams and shared mission — all aimed at a larger pursuit of access ...

During this session, the panelists discussed medical communications and market access with a particular focus on commercialization. The discussion focused on how firms are leveraging technology and AI ...

The European market for orphan drugs presents many opportunities and challenges for pharma companies. With over 30 million people in the EU living with rare diseases, the demand for innovative ...

As the adage goes, if you’ve met one US healthcare system, you’ve met one US healthcare system. Repeatable, predictable processes for global health-focused startups seeking to commercialize in the US ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. You may be hearing about the expansion of private markets ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced its first major market access wins in the 2025 Medicare Part D ...